N

NewGLab Pharma Co Ltd
KOSDAQ:214870

Watchlist Manager
NewGLab Pharma Co Ltd
KOSDAQ:214870
Watchlist
Price: 6 915 KRW -27.44% Market Closed
Market Cap: 323.6B KRW
Have any thoughts about
NewGLab Pharma Co Ltd?
Write Note
NewGLab Pharma Co Ltd
/
Income Statement
/
Net Income (Common)

NewGLab Pharma Co Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

NewGLab Pharma Co Ltd
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
N
NewGLab Pharma Co Ltd
KOSDAQ:214870
Net Income (Common)
₩290.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
V
Vidente Co Ltd
KOSDAQ:121800
Net Income (Common)
₩16.2B
CAGR 3-Years
-55%
CAGR 5-Years
N/A
CAGR 10-Years
37%
T
Tovis Co Ltd
KOSDAQ:051360
Net Income (Common)
₩41.6B
CAGR 3-Years
N/A
CAGR 5-Years
12%
CAGR 10-Years
7%
F
Furonteer Co Ltd
KOSDAQ:370090
Net Income (Common)
₩7.5B
CAGR 3-Years
N/A
CAGR 5-Years
66%
CAGR 10-Years
N/A
P
Park Systems Corp
KOSDAQ:140860
Net Income (Common)
₩30.4B
CAGR 3-Years
78%
CAGR 5-Years
65%
CAGR 10-Years
N/A
W
Woori Technology Inc
KOSDAQ:032820
Net Income (Common)
₩306.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

NewGLab Pharma Co Ltd
Glance View

Market Cap
323.6B KRW
Industry
Electrical Equipment

NewGLAB Pharma Co., Ltd. engages in the manufacture of closed-circuit television camera and equipment. The company is headquartered in Bucheon, Gyeonggi-Do. The company went IPO on 2015-10-13. The firm's product portfolio consists of general analog cameras that used for CCTVs, high definition (HD) analog cameras, HD-serial digital interface (SDI) cameras, extend (EX)-SDI cameras, internet protocol (IP) cameras that used for network CCTVs, digital video recorders (DVRs) that used for image storage devices, network video recorders (NVRs) and others. In addition, the Company is involved in the business of 5G smartphone distribution. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
84.39 KRW
Overvaluation 99%
Intrinsic Value
Price
N
What is Intrinsic Value?

See Also

What is NewGLab Pharma Co Ltd's Net Income (Common)?
Net Income (Common)
290.5m KRW

Based on the financial report for Sep 30, 2024, NewGLab Pharma Co Ltd's Net Income (Common) amounts to 290.5m KRW.

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.